No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.

Clin Rheumatol · 2009 · PMC2686804 · PMID 19350343

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

showed a trendp = 0.075so close (0.05 < p ≤ 0.1)

The DAT showed a trend to be longer after 16 weeks of treatment ( p = 0.075) and was significantly longer at week 20 ( p = 0.044) when compared to baseline.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.